TuHURA Biosciences, Inc. HURA Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $0— | $0— | $0— | $0— | $0— | ||
| $5.23M+14.2% | $6.06M+52.3% | $4.97M+68.6% | $4.93M+74.5% | $4.58M+27.7% | ||
| $2.3M+13.9% | —— | $1.76M+125% | $4.95M+522% | $2.02M+98.3% | ||
| $7.53M+7.3% | $8.17M+43.5% | $6.73M+80.4% | $9.88M+173% | $7.02M+52.4% | ||
| $27.97K— | $608.75K+16.4% | $16.53K-99.2% | —— | —— | ||
| -$6.7K-102% | $1.41M-63.4% | -$372.85K-877% | $352.12K+121% | $352.65K+377% | ||
| -$7.54M-13.1% | -$6.76M-12.8% | -$7.1M-27.3% | -$9.52M-80.9% | -$6.66M-37.6% | ||
| -$0.13+13.3% | -$0.13— | -$0.14+74.1% | -$0.21+51.2% | -$0.15+62.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Is TuHURA Biosciences, Inc. profitable?
- TuHURA Biosciences, Inc. is not currently profitable: it reported a net loss of $30.9M over the trailing twelve months.
- What is TuHURA Biosciences, Inc.'s earnings per share?
- TuHURA Biosciences, Inc.'s diluted EPS over the trailing twelve months is $-0.61.
- Where does TuHURA Biosciences, Inc.'s income statement data come from?
- Every line is extracted from TuHURA Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.